Particle.news
FDA FDA Regulations Clinical Trials Regulatory Agencies NHS Policies Generic Drugs Alzheimer's Disease EU Regulations NHS Public Health Eli Lilly Nasal Spray Esketamine FDA Drug Approval Xolair Cardiovascular Health Regulations Guidelines TGA NHS Treatments Regulatory Authorities Imdelltra Insurance Coverage Biotechnology Regulatory Affairs Therapeutic Goods Administration Mounjaro Vorasidenib MHRA EU Commission European Medicines Agency Mifepristone Infant Medicine FDA Approval Blood Disorder Treatment China Non-Hormonal Treatments FDA Processes Weight Management Bristol Myers Squibb Antipsychotic Medications
The clearance bolsters J&J’s neuroscience strategy following its $14.6 billion Intra‑Cellular Therapies acquisition.
